-
Mashup Score: 0Developmental lung anomalies in adults: A pictorial review - 1 year(s) ago
Developmental lung anomalies represent a heterogeneous group of diverse, yet related abnormalities that involve the lung parenchyma, pulmonary vasculature or a combination of both-which usually present prenatally and in early childhood. However, a substantial number of cases go unnoticed during childhood and present either incidentally or with recurrent respiratory infections progressing into…
Source: Respiratory MedicineCategories: Critical Care, Latest HeadlinesTweet
-
Mashup Score: 0The spectrum of pulmonary aspergillosis - 1 year(s) ago
Notable progress has been made in the past years in the classification, diagnosis and treatment of pulmonary aspergillosis. New criteria were proposed by the Working Group of the International Society for Human and Animal Mycology (ISHAM) for the diagnosis of allergic bronchopulmonary aspergillosis (ABPA). The latest classification of chronic pulmonary aspergillosis (CPA) suggested by the…
Source: Respiratory MedicineCategories: Latest Headlines, PulmonologyTweet-
Nice @SyedHussain1990! CT shows halo sign of which invasive pulmonary aspergillosis is one cause, and you got the isavuconazole even without the "z" ... Here is a free full text review article on the spectrum of pulmonary aspergillus disease: https://t.co/gMVWrCqkYO
-
-
Mashup Score: 0Towards development of evidence to inform recommendations for the evaluation and management of bronchiectasis - 1 year(s) ago
Bronchiectasis (BE) is a chronic condition characterized by airway dilation as a consequence of a variety of pathogenic processes. It is often associated with persistent airway infection and an inflammatory response resulting in cough productive of purulent sputum, which has an adverse impact on quality of life. The prevalence of BE is increasing worldwide. Treatment guidelines exist for managing…
Source: Respiratory MedicineCategories: Latest Headlines, PulmonologyTweet-
Towards development of evidence to inform recommendations for the #evaluation and #management of #bronchiectasis https://t.co/bC8sBjKGFV https://t.co/wqEkcNDCjK
-
-
Mashup Score: 1Establishing a balloon pulmonary angioplasty program for chronic thromboembolic pulmonary hypertension: A United States single-center experience - 1 year(s) ago
Balloon pulmonary angioplasty (BPA) is a less invasive treatment alternative for patients with chronic thromboembolic pulmonary hypertension (CTEPH) who are unable to move forward with pulmonary thromboendarterectomy. This report describes a single-center experience with a nascent BPA program in the United States (US).
Source: Respiratory MedicineCategories: Latest Headlines, PulmonologyTweet-
Establishing a balloon #pulmonary #angioplasty program for #chronic #thromboembolic #pulmonaryhypertension: A United States single-center experience https://t.co/zenjVwdeTu https://t.co/jLOUqTrB9J
-
-
Mashup Score: 0
A novel, once-daily, fixed-dose combination of mometasone furoate/indacaterol acetate/glycopyrronium bromide (MF/IND/GLY) delivered via Breezhaler® is the first inhaled corticosteroid/long-acting ꞵ2-agonist/long-acting muscarinic antagonist (ICS/LABA/LAMA) therapy approved for the maintenance treatment of asthma in adults inadequately controlled on ICS/LABA combination. In patients with asthma…
Source: Respiratory MedicineCategories: Latest Headlines, PulmonologyTweet-
#Efficacy of once-daily, single-#inhaler, fixed- #dose combination of #mometasone/ #indacaterol/ #glycopyrronium in #patients with #asthma with or without persistent #airflow limitation: Post hoc #analysis from the IRIDIUM study https://t.co/lVuSNIUyha https://t.co/KnTfrLmZ2t
-
-
Mashup Score: 1Prevalence of abnormal spirometry in individuals with a smoking history and no known obstructive lung disease - 1 year(s) ago
Recent evidence suggests a high prevalence of undiagnosed chronic obstructive pulmonary disease (COPD). These individuals are at risk of exacerbations and delayed treatment. We analyzed an at-risk population for the prevalence of abnormal spirometry to provide clarity into who should undergo early spirometry.
Source: Respiratory MedicineCategories: Latest Headlines, PulmonologyTweet-
Prevalence of #abnormal #spirometry in individuals with a #smoking #history and no known #obstructive #lung #disease https://t.co/tIV2AG0xLO https://t.co/ap0ljLXBWu
-
-
Mashup Score: 0Palliative care referrals in patients with pulmonary arterial hypertension: The Pulmonary Hypertension Association Registry - 1 year(s) ago
Pulmonary arterial hypertension (PAH) is a life limiting disease with substantial symptom burden and healthcare utilization. Palliative care alleviates physical and emotional symptoms for patients with serious illness, and has been underutilized for these patients.
Source: Respiratory MedicineCategories: Latest Headlines, Palliative MedicineTweet-
📰 'Palliative Care Referrals in Patients with Pulmonary Arterial Hypertension (PAH)' >>https://t.co/UyWVrnkuJi A study in Respiratory Medicine found that #palliativecare can benefit patients w/ PAH and help patients cope with the significant physical and psychological symptoms. https://t.co/kMTae4UjPE
-
-
Mashup Score: 0
Persistent cigarette smoking is associated with reduced airflow even in young adults. Cannabis use does not appear to be related to lung function even after years of use.
Source: Respiratory MedicineCategories: Healthcare Professionals, Latest HeadlinesTweet-
Do tobacco and cannabis use and co-use predict lung function: A longitudinal study - Respiratory Medicine https://t.co/VDHsye7r7d
-
-
Mashup Score: 0Palliative care referrals in patients with pulmonary arterial hypertension: The Pulmonary Hypertension Association Registry - 1 year(s) ago
Pulmonary arterial hypertension (PAH) is a life limiting disease with substantial symptom burden and healthcare utilization. Palliative care alleviates physical and emotional symptoms for patients with serious illness, and has been underutilized for these patients.
Source: Respiratory MedicineCategories: Latest Headlines, PulmonologyTweet-
#PalliativeCare referrals in patients with #pulmonary arterial #hypertension: The Pulmonary Hypertension Association Registry https://t.co/jdHrQj0FGb https://t.co/XVcxcFLFbb
-
-
Mashup Score: 0
Smoking is the major risk factor for chronic obstructive pulmonary disease (COPD). In IMPACT, single-inhaler fluticasone furoate/umeclidinium/vilanterol (FF/UMEC/VI) triple therapy significantly reduced moderate/severe exacerbation rates and improved lung function and health status versus FF/VI or UMEC/VI in COPD patients. This post hoc analysis investigated trial outcomes by smoking status.
Source: Respiratory MedicineCategories: Critical Care, Latest HeadlinesTweet-
Single #inhaler triple #therapy fluticasone furoate/umeclidinium/vilanterol versus dual therapy in current and former #smokers with #COPD: IMPACT trial post hoc analysis https://t.co/MN8Qrt8dRl https://t.co/aRBOXsrRBK
-
Nice @SyedHussain1990 and @pkramer88! aka hypogenetic lung syndrome (HLS) or pulmonary venolobar syndrome... here is a nice, free full text pictorial review on developmental abnormalities: https://t.co/ECQ1hJDPae Hope everyone has a great weekend!